School of Medicine and Surgery, University of Milano-Bicocca, Monza, 20900, Italy.
Neurosurgery, Fondazione IRCCS San Gerardo dei Tintori, 20900, Monza, Italy.
Neurosurg Rev. 2024 Sep 30;47(1):706. doi: 10.1007/s10143-024-02905-z.
Endoscopic transorbital approaches (ETOAs) are finding wide application for skull base lesions, particularly for spheno-orbital meningiomas (SOMs). These tumors have high recurrence rates, and second surgery can often represent a challenge. In this study we analyze our experience of management of recurrent SOMs through a slightly modified eyelid crease approach. Between May 2016 and September 2023, in the Department of Neurosurgery of Fondazione IRCCS Policlinico San Matteo (Pavia, Italy), five consecutive recurrent SOMs have been treated using an endoscopic transorbital approach. Demographic data, preoperatory deficits, lesions characteristics, histology, grade of resection, eventual adjuvant treatments, complications, outcome in terms of symptoms improvement and cosmesis, and hospitalization are described. One patient maintained a right lateral rectus muscle palsy that was already present in the preoperatory, no cerebrospinal fluid (CSF) leaks were reported. All patients had postoperative periorbital edema, but no other systemic complication was found. All patients had proptosis improvement, two had visual acuity improvement, and best cosmetic outcome was obtained in all cases. Hospitalization varied between 4 and 6 days. ETOAs in the management of recurrent SOMs are safe and have good outcome. Right selection of patients is mandatory, but when feasible, endoscopic surgery can allow a virgin route to a previously operated tumor, guaranteeing a good strategic option.
经眶内窥镜手术(ETOA)在颅底病变的治疗中得到了广泛的应用,特别是在蝶眶脑膜瘤(SOM)的治疗中。这些肿瘤的复发率很高,再次手术往往是一个挑战。在这项研究中,我们通过略微改良的眼睑皱褶入路分析了我们治疗复发性 SOM 的经验。2016 年 5 月至 2023 年 9 月,在意大利帕维亚的圣马特奥基金会 IRCCS 神经外科系(Policlinico San Matteo),连续 5 例复发性 SOM 患者采用经眶内窥镜手术治疗。描述了人口统计学数据、术前缺陷、病变特征、组织学、切除程度、可能的辅助治疗、并发症、症状改善和美容效果以及住院情况。1 例患者仍存在右侧外直肌麻痹,该麻痹在术前已经存在,未报告脑脊液(CSF)漏。所有患者术后均出现眶周水肿,但未发现其他全身并发症。所有患者的眼球突出均有改善,2 例视力有改善,所有病例均获得最佳美容效果。住院时间为 4 至 6 天。在 SOM 复发病例的治疗中,ETOA 是安全的,且效果良好。必须正确选择患者,但在可行的情况下,内窥镜手术可以为以前手术过的肿瘤提供新的途径,确保了一个良好的治疗策略。